RCS - ConvaTec Group PLC - ConvaTec Launches Sensi-Care® <Origin Href="QuoteRef">CTEC.L</Origin>

ConvaTecAnnouncement

23/03/2017 07:07

RNS Number : 2319A
ConvaTec Group PLC
23 March 2017
ConvaTec Launches Sensi-Care Skin Protectant Incontinence Wipes, Expanding Core Wound Business and Protecting Patients' Skin
 Expansion of Sensi-Care portfolio in $500m market for skin care wipes, providing customers with advanced, evidence-based1 solutions to cleanse, moisturize and protect patients' skin
READING, UNITED KINGDOM (23 March 2017) - ConvaTec Group Plc ("ConvaTec"), a leading global medical technology company, today announced the U.S. launch of Sensi-Care Skin Protectant Incontinence Wipes, providing customers with an advanced solution to help protect patients with skin at risk of breakdown due to incontinence.
The launch expands the company's presence in a growing segment of the $500 million wipes market, and adds to its portfolio that helps protect the skin, which includes Aloe Vesta and Sensi-Care cleansers, moisturizers, and moisture barriers, and supporting products such as AQUACEL Foam Pro dressings and Flexi-Seal( Signal Fecal Management Systems.
Sensi-Care Skin Protectant Incontinence Wipes are designed to help care providers cleanse patients' delicate skin following episodes of incontinence. Formulated with an optimal combination of skin care ingredients, the new wipes help treat and prevent incontinence-associated dermatitis (IAD).2
IAD, which is estimated to affect half of people with urinary or fecal incontinence,2 is a condition where the skin becomes irritated and inflamed and, if not treated appropriately, severely swollen and blistered. The occurrence of IAD is also associated with an increased risk for the development of pressure injuries (pressure ulcers) and infection.3
Sensi-Care Skin Protectant Incontinence Wipes feature a dual-texture design - smooth on one side and textured on the other - for more efficient cleansing of delicate areas. The disposable wipes may also be warmed for use, to increase patient comfort.* The ingredients in the wipes allow a caregiver to cleanse, moisturize, and protect the skin in one step.
"Episodes of urinary and fecal incontinence, distressing and uncomfortable for patients, can lead to skin damage and increase the risk of pressure injury development and infection," said Fiona Adam, Vice President and General Manager, Advanced Wound Care. "Our Sensi-Care portfolio including our new incontinence wipes was developed to answer the specific needs of care providers and patients, providing advanced formulations and easy-to-use products to help clinicians lessen these risks.
"ConvaTec is committed to providing a comprehensive range of products that can help healthcare professionals protect patients' skin, including advanced dressings such as AQUACEL Foam Pro and our Flexi-Seal systems for managing acute fecal incontinence." 
Sensi-Care Evidence-based Skin Care
In addition to caring for patients' skin, ConvaTec's Sensi-Care skin care range was developed to provide healthcare professionals with solutions that can help them achieve consistent clinical and economic outcomes. 
Sensi-Care skin care products work together in a simple 1-2-3 system to cleanse, moisturize and protect sensitive skin that is already compromised. The line includes Sensi-Care Body Wash & Shampoo, Perineal/Skin Cleanser, Body Cream, Protective Barrier, and Clear Zinc Skin Protectant. The 3-step skin care system provides a simple and proven solution designed to help maintain skin integrity, optimize resources and ensure consistency of care1 - delivering results that benefit everyone in healthcare.
Sensi-Care Skin Protectant Incontinence Wipes have a skin-friendly pH level, are fragrance free, and available in convenient, re-sealable packs of eight 8"x10" wipes. 
For more information about Sensi-Care Skin Protectant Incontinence Wipes and the company's Sensi-Care and Aloe Vesta skin care lines, visit www.convatec.com or call ConvaTec customer service at 1-800-422-8811.
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com
Enquiries
Bobby Leach, VP Group Corporate Affairs, ConvaTec  +44 (0)7770 842 226
Punnie Donohue, VP Communications, ConvaTec             +1 (908) 745 9031
Rebecca Fitchett, Finsbury                             +44 (0)207 251 3801
# # #
*Sensi-Care Skin Protectant Wipes should not be used hot, and should not be flushed.
TM/ indicate trademarks of ConvaTec Inc. 
 2017 ConvaTec Inc. 
AP-017540-US
References:
1Lyder CH, Shannon R, Empleo-Frazier O, McGeHee D, White C. A comprehensive program to prevent pressure ulcers in long-term care: exploring costs and outcomes. Ostomy Wound Manage. 2002;48(4):52-62
2Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs. 2011;38(6):627-634
3Doughty, D., Junkin, J., Kurz, P., Selekof, J., Gray, M., Fader, M. et al (2012) Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and current challenges. Journal of Wound Ostomy, and Continence Nursing. May-June; 39(3): 303-3215. Quiz 316-317.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NRADMGZFDZZGNZM